Altum Pharmaceuticals INC   Report issue

For profit Phase 2
Founded: Vancouver Canada (2016)
Status: Acquired by BetterLife Pharma (2020)

Organization Overview

First Clinical Trial
2019
NCT04143789
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Altum Pharmaceuticals | Altum Pharmaceuticals INC

Active Ingredients

Drugs in Phase 2 Trials (2)

ap-002 (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2